Message Number: FHL2702 | New FHL Archives SearchFrom: Sukie Crandall
Date: Sun, 14 Oct 2007 04:07:31 -0400
To: ferrethealth@yahoogroups.com
Subject: [ferrethealth] abstracts: a confirmed Cushings case and treatment; SARS
> Domest Anim Endocrinol. 2007 Sep 10; [Epub ahead of print]
>
> Links
> Luteinizing hormone-dependent Cushing's syndrome in a pet ferret
> (Mustela putorius furo).
>
> Schoemaker NJ, Kuijten AM, Galac S.
> Division of Avian and Exotic Animal Medicine of the Department of
> Clinical Sciences of Companion Animals, Faculty of Veterinary
> Medicine, Utrecht University, Yalelaan 108, 3584 CM Utrecht, The
> Netherlands.
> Hyperadrenocorticism in ferrets is associated with increased
> circulating concentrations of adrenal androgens, whereas plasma
> concentrations of cortisol and ACTH are usually not affected. Here,
> we report on a 5-year-old castrated male pet ferret (Mustela
> putorius furo) in which the major presenting signs were polyuria
> and polyphagia. Routine biochemistry values were within their
> reference ranges. The urinary corticoid:creatinine ratio (UCCR) was
> increased and the plasma ACTH concentration was suppressed.
> Abdominal ultrasonography revealed an enlarged right adrenal gland
> and atrophy of the left adrenal gland. Administration of hCG
> resulted in an increase of plasma cortisol and androstenedione
> concentrations. Based on these findings LH/hCG-dependent
> hypercortisolism and hyperandrogenism were suspected and treatment
> was started with a depot GnRH-agonist implant containing 9.4mg
> deslorelin. Within 3 weeks after placement of the implant all
> clinical signs had disappeared. Three months later the endocrine
> parameters had normalized, while abdominal ultrasonography revealed
> that the right adrenal gland had diminished in size and the left
> adrenal gland was considered of normal size. No recurrences of
> clinical signs were seen within 2 years after placement of the
> deslorelin implant. At that time urinary corticoid and plasma
> hormone concentrations were within their reference ranges, and no
> further change in the size of the adrenal glands was seen. In
> conclusion, this is the first confirmed case of LH-dependent
> hypercortisolism in a ferret that was treated successfully with a
> depot GnRH-agonist.
> PMID: 17920804 [PubMed - as supplied by publisher]
> J Infect Dis. 2007 Nov 1;196(9):1329-38. Epub 2007 Sep 27.
>
> Links
> Severe acute respiratory syndrome coronavirus infection in
> vaccinated ferrets.
>
> Darnell ME, Plant EP, Watanabe H, Byrum R, St Claire M, Ward JM,
> Taylor DR.
> Laboratory of Hepatitis and Related Emerging Agents, Division of
> Emerging and Transfusion-Transmitted Diseases, Office of Blood
> Research and Review, CBER FDA, Bethesda, MD, 20892, USA.
> Deborah.Taylor@FDA.HHS.gov.
> Background. Development of vaccines to prevent severe acute
> respiratory syndrome (SARS) is limited by the lack of well-
> characterized animal models. Previous vaccine reports have noted
> robust neutralizing antibody and inflammatory responses in ferrets,
> resulting in enhanced hepatitis.Methods. We evaluated the humoral
> immune response and pathological end points in ferrets challenged
> with the Urbani strain of SARS-associated coronavirus (SARS-CoV)
> after having received formalin-inactivated whole-virus vaccine or
> mock vaccine.Results. Humoral responses were observed in ferrets
> that received an inactivated virus vaccine. Histopathological
> findings in lungs showed that infection of ferrets produced
> residual lung lesions not seen in both mock and vaccinated ferrets.
> SARS-CoV infection demonstrated bronchial and bronchiolar
> hyperplasia and perivascular cuffing in ferret lung tissue, as seen
> previously in infected mice. No evidence of enhanced disease was
> observed in any of the ferrets. All of the ferrets cleared the
> virus by day 14, 1 week earlier if vaccinated.Conclusions. The
> vaccine provided mild immune protection to the ferrets after
> challenge; however, there was no evidence of enhanced liver or lung
> disease induced by the inactivated whole-virus vaccine. The ferret
> may provide another useful model for evaluating SARS vaccine safety
> and efficacy.
> PMID: 17922397 [PubMed - in process]
Sukie (not a vet)
Recommended ferret health links:
http://pets.groups.yahoo.com/group/ferrethealth/
http://ferrethealth.org/archive/
http://www.afip.org/ferrets/index.html
http://www.miamiferret.org/fhc/
http://www.ferretcongress.org/
http://www.trifl.org/index.shtml
http://homepage.mac.com/sukie/sukiesferretlinks.html
[Non-text portions of this message have been removed]
Yahoo! Groups Links
<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/ferrethealth/
<*> Your email settings:
Individual Email | Traditional
<*> To change settings online go to:
http://groups.yahoo.com/group/ferrethealth/join
(Yahoo! ID required)
<*> To change settings via email:
mailto:ferrethealth-digest@yahoogroups.com
mailto:ferrethealth-fullfeatured@yahoogroups.com
<*> To unsubscribe from this group, send an email to:
ferrethealth-unsubscribe@yahoogroups.com
<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/
Send comments to Pam at pjdutche@email.unc.edu. Please note that this address is only useful for questions about the FHL archive. Questions about ferret health, or those intended for the FHL, should be sent to the Ferret Health List.